Great West Life Assurance CO Cerus Corp Transaction History

Great West Life Assurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $51,682 - $105,776	34,455 Added 44.15%	112,487 $181,000
Q2 2023 Aug 10, 2023	BUY	$1.79 - $2.9 $35,214 - $57,051	19,673 Added 33.71%	78,032 $192,000
Q4 2022 Feb 10, 2023	BUY	$3.38 - $4.22 $61,698 - $77,031	18,254 Added 45.52%	58,359 $214,000
Q3 2022 Nov 01, 2022	BUY	$3.43 - $5.83 $101,483 - $172,492	29,587 Added 281.3%	40,105 $144,000
Q2 2022 Aug 12, 2022	BUY	$4.41 - $5.69 $46,384 - $59,847	10,518 New	10,518 $56,000
Q2 2022 Aug 09, 2022	SELL	$4.41 - $5.69 $46,384 - $59,847	-10,518 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$5.78 - $7.47 $60,794 - $78,569	10,518 New	10,518 $65,000
Q3 2020 Nov 13, 2020	SELL	$5.78 - $7.47 $60,794 - $78,569	-10,518 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$3.84 - $4.86 $40,389 - $51,117	10,518 New	10,518 $44,000
Q3 2019 Oct 25, 2019	SELL	$4.86 - $6.05 $96,344 - $119,935	-19,824 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$4.89 - $7.16 $56,841 - $83,227	11,624 Added 141.76%	19,824 $97,000
Q3 2017 Nov 09, 2017	BUY	$2.22 - $2.73 $18,204 - $22,386	8,200	8,200 $22,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $294M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.